Cite
HARVARD Citation
Nishikawa, K. et al. (n.d.). 2329 A randomized phase III study of S-1 alone versus S-1 plus immunomodulator lentinan for unresectable or recurrent gastric cancer (JFMC36–0701). European journal of cancer. pp. S442-. [Online].